Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-03-08 Tax Withholding | 2021-03-10 5:38 pm | N/A N/A | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 5,221 | $33.37 | 147,346 (Direct) | View |
| 2021-02-24 Option Award | 2021-02-26 7:25 pm | N/A 2031-02-24 | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 60,700 | $0 | 192,467 (Direct) | View |
| 2020-12-07 Tax Withholding | 2020-12-09 7:33 pm | N/A N/A | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 2,728 | $41.99 | 131,767 (Direct) | View |
| 2020-11-17 Exercise | 2020-11-19 4:52 pm | N/A N/A | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 7,082 | $14.57 | 134,495 (Direct) | View |
| 2020-11-17 Exercise | 2020-11-19 4:52 pm | N/A 2024-03-19 | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 7,082 | $0 | 134,495 (Direct) | View |
| 2020-09-08 Tax Withholding | 2020-09-10 7:32 pm | N/A N/A | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 2,728 | $42.16 | 127,413 (Direct) | View |
| 2020-06-08 Tax Withholding | 2020-06-10 7:45 pm | N/A N/A | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 2,728 | $33.61 | 130,141 (Direct) | View |
| 2020-03-06 Tax Withholding | 2020-03-18 8:03 pm | N/A N/A | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 6,525 | $39.71 | 194,691 (Direct) | View |
| 2020-03-17 Option Award | 2020-03-18 8:03 pm | N/A 2030-03-17 | FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety | 100,000 | $0 | 194,691 (Direct) | View |